London, United Kingdom

Ian D Hiles


Average Co-Inventor Count = 7.3

ph-index = 8

Forward Citations = 289(Granted Patents)


Location History:

  • Bromley, GB (1998)
  • London, GB (1996 - 2011)

Company Filing History:


Years Active: 1996-2011

Loading Chart...
24 patents (USPTO):Explore Patents

Title: Ian D. Hiles: Pioneering Advances in Glial Cell Research

Introduction

Ian D. Hiles, based in London, GB, is a notable inventor with an impressive portfolio of 24 patents to his name. His innovative work primarily focuses on glial cell biology, contributing significantly to the understanding and treatment of glial cell tumors. His research has paved the way for the development of therapeutic and diagnostic methods vital for treating diseases associated with glial cells.

Latest Patents

Among his latest patents, Hiles has developed groundbreaking work on "Glial mitogenic factors, their preparation and use." This innovation details the characterization and purification of DNA encoding numerous polypeptides vital for stimulating glial cell mitogenesis, particularly in Schwann cells, and treating glial cell tumors. The patent involves DNA sequences that encode novel polypeptides which may be utilized for therapeutic and diagnostic purposes. Furthermore, the methods outlined provide a framework for the synthesis, purification, and testing of both known and novel polypeptides, ensuring their effectiveness as diagnostic and therapeutic aids in diseases involving glial cells. Notably, it also includes techniques for preparing antibody probes applicable in both diagnostic and therapeutic scenarios.

Career Highlights

Ian D. Hiles has made remarkable strides in his career, working with esteemed institutions such as the Ludwig Institute for Cancer Research Limited and Acorda Therapeutics, Inc. His efforts in these organizations have allowed him to merge research with practical applications, leading to significant advancements in the field of cell biology.

Collaborations

Throughout his career, Hiles has collaborated with other notable scientists, including Michael Derek Waterfield and Andrew David Goodearl. These partnerships have facilitated the sharing of expertise and resources, furthering the innovation landscape in glial cell research.

Conclusion

Ian D. Hiles stands out as a distinguished inventor whose contributions to glial cell biology have substantial implications for the treatment of related diseases. His notable patents, combined with his collaborative efforts within esteemed institutions, underscore his commitment to advancing medical science through innovation. As he continues to develop new methodologies and applications, Hiles exemplifies the vital role of inventors in shaping the landscape of modern medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…